“hnRNPM guides an alternative splicing program in response to inhibition of the PI3K/AKT/mTOR pathway in Ewing sarcoma cells.”
Passacantilli I, Frisone P, De Paola E, Fidaleo M, Paronetto MP.
Nucleic Acids Res. 2017 Oct 3
Categories: Article
Article
In J Exp Clin Cancer Res: Splicing targeting drugs highlight intron retention as an actionable vulnerability in advanced prostate cancer
Splicing targeting drugs highlight intron retention as an actionable vulnerability in advanced prostate cancer Chiara Naro, Ambra Antonioni, Vanessa Medici, Cinzia Caggiano, Ariane Jolly, Pierre de la Grange, Pamela Bielli, Maria Paola Paronetto, Claudio Sette Read more…